A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan. [electronic resource]
Producer: 20060526Description: 73-81 p. digitalISSN:- 1478-3223
- Adult
- Antiviral Agents -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- diagnosis
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Liver Function Tests
- Male
- Maximum Tolerated Dose
- Middle Aged
- Pilot Projects
- Polyethylene Glycols
- Probability
- ROC Curve
- Recombinant Proteins
- Reference Values
- Ribavirin -- administration & dosage
- Risk Assessment
- Severity of Illness Index
- Single-Blind Method
- Taiwan
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.